annb0t
Top 20
ResMed Inc.âs RMD adjusted earnings per share (EPS) in the fourth quarter of fiscal 2023 were $1.60, up 7.4% year over year. However, the metric missed the Zacks Consensus Estimate by 4.2%.
The adjustments include certain non-recurring expenses/benefits like the amortization of acquired intangibles, restructuring and acquisition-related expenses, among others.
GAAP EPS in the reported quarter was $1.56, up 17.3% from the year-ago quarterâs EPS.
For the full year, adjusted EPS was $6...
>>> Read more: ResMed's (RMD) Q4 Earnings Miss, Revenues Beat Estimates
The adjustments include certain non-recurring expenses/benefits like the amortization of acquired intangibles, restructuring and acquisition-related expenses, among others.
GAAP EPS in the reported quarter was $1.56, up 17.3% from the year-ago quarterâs EPS.
For the full year, adjusted EPS was $6...
>>> Read more: ResMed's (RMD) Q4 Earnings Miss, Revenues Beat Estimates
